Nordic Nanovector
Kjelsåsveien 168 B
Oslo
0884
Tel: 47-22-18-33-01
Fax: 47-22-58-00-07
Website: http://www.nordicnanovector.no/
Email: mail@nordicnanovector.no
343 articles about Nordic Nanovector
-
Nordic Nanovector: Poster Presentation Of Preclinical Studies Comparing Betalutin With LU-177 Chimeric Anti-CD37 Antibody Radionuclide Conjugate
10/27/2015
-
Nordic Nanovector ASA – MANDATORY NOTIFICATION OF TRADE
10/26/2015
-
Nordic Nanovector: Results For The Third Quarter And First Nine Months Of 2015
10/21/2015
-
Nordic Nanovector Third Quarter 2015 Results Presentation And Webcast
10/14/2015
-
Nordic Nanovector: Results For The Second Quarter And Half Year 2015
8/26/2015
-
Nordic NanovectorTo Present at Pareto Securities’ 6th Annual Health Care Seminar
8/20/2015
-
Nordic Nanovector: Second Quarter And Half Year 2015 Results Presentation And Webcast
8/18/2015
-
Nordic Nanovector: NANO – Mandatory Notification Of Trade
6/19/2015
-
Nordic Nanovector: Updated Results Of Ongoing Phase 1/2 Study With Betalutin In Relapsed CD37+ Non-Hodgkin Lymphoma Patients
6/17/2015
-
Nordic Nanovector Appoints New Scientific Advisory Board
5/21/2015
-
Nordic Nanovector Schedules First Quarter 2015 Results Presentation And Webcast
5/13/2015
-
Nordic Nanovector – Share Capital Increase Registered
4/24/2015
-
Nordic Nanovector: Results Of Phase 1 Study Of Betalutin In Patients With Non-Hodgkin Lymphoma To Be Presented At The International Conference On Malignant Lymphoma
4/23/2015
-
Nordic Nanovector: Nano – Mandatory Notification Of Trade
3/25/2015
-
Nordic Nanovector: Nano – Mandatory Notification Of Trade
3/20/2015
-
Nordic Nanovector - Recommendation Of The Nomination Committee
3/3/2015
-
Nordic Nanovector - Approved Listing Application
2/25/2015
-
Nordic Nanovector – Fourth Quarter Report 2014
2/23/2015
-
Nordic Nanovector – Fourth Quarter Report 2014
2/23/2015
-
Nordic Nanovector To Present At 7th Annual Biotech Showcase Conference In San Francisco On 13 January 2015
1/9/2015